Efficacy of Galcanezumab for Migraine Prevention in Patients With a Medical History of Anxiety and/or Depression: A Post Hoc Analysis of the Phase 3, Randomized, Double-Blind, Placebo-Controlled REGAIN, and Pooled EVOLVE-1 and EVOLVE-2 Studies.

ABSTRACT:

SUBMITTER: Smitherman TA 

PROVIDER: S-EPMC7756873 | biostudies-literature | 2020 Nov

REPOSITORIES: biostudies-literature